TSLA · Tesla, Inc. — research history

Stage crashed before producing an artifact (e.g. LM Studio timeout, malformed JSON, network error). The cooldown will hold this off the queue for ~1h before retry.

TSLA trades at ~$396, below both its MA50 ($402) and MA200 ($417), with RSI neutral at 45.1 and a recent bearish MACD cross. Fundamentals are solid (market cap $1.48T, cash $44B vs debt $16B, positive FCF $5.25B). The stock has recovered sharply from its March lows (~$355) but remains ~19% off its 52-week high of ~$490 and ~5% below the 200DMA — giving a reasonable margin-of-safety at lower strike CSPs. However, TSLA reports Q2 FY2026 earnings on July 22, 2026 (4 days after the nearest viable expiry of Jul-17; squarely inside every candidate window). IV data shows anomalous sub-7% readings from the chain tool — likely a feed artifact — but even accepting that number at face value, earnings proximity means any premium collected is subject to catastrophic IV crush. This makes every 25–50 DTE contract either straddling or dangerously close to an earnings event with unknown directional risk (TSLA has missed EPS on 2 of last 4 quarters and shows high beta). The anti-signal is unambiguous: reject all structures where expiry falls within the earnings window.

Now I have enough data to compile a comprehensive dossier. Let me assemble the findings: {"symbol":"TSLA","company":"Tesla, Inc.","investigation_summary":"Tesla presents a deeply complex investment case: strong Q1 2026 EPS beat ($0.41 actual vs $0.35 est), revenue growth of ~16% YoY to $22.4B, but forward P/E of 162x and EV/EBITDA of 134x render the stock severely overvalued on fundamentals alone

TSLA trades at extreme valuation multiples (forward P/E 156x, EV/EBITDA 139x) with nil insider open-market buying and declining regulatory credit tailwinds. Q1 2026 was a genuine beat (+17% EPS surprise, automotive gross margin rebounded to 21.1%) but the stock is priced for autonomous-robotaxi perfection — any softness in the July 22 earnings report creates sharp downside risk. The put-side whale positioning on OTM strikes ($350-$405) reflects legitimate macro/SpaceX-IPO diversion concern, not a fundamental mispricing of TSLA itself. No smart-money cluster present; no hidden filing edge identified.

Extreme valuation (174x FPE, 147x EV/EBITDA), compressing automotive margins, zero insider buying, and material anti-signals (dilution, accounting) make this unsuitable for publication or paper-tracking.

TSLA presents an extreme valuation case — PE forward of 174x and EV/EBITDA of 147x on thin 4% operating margins. The options flow showing 41%+ net $ bullish bias is real but corroborates sentiment rather than mispricing; the stock is near 52w highs, has appreciated +22% YTD, and fundamentally does not meet the 'mispriced vs intrinsic' criterion at current levels. The Robotaxi catalyst exists (launched June 2025) but Texas DMV data shows only 42 authorized vehicles vs Waymo's 577 — a concrete disappointment vs narrative. Q1 EPS beat (+17%) is positive but insufficient to justify the multiple. No open-market insider purchases in 90d; all Form 4 activity from this period reflects options-exercise sells and pre-planned 10b5-1 sales by CFO Taneja. The bull thesis (FSD, Optimus, Megapack/AI grid storage) is priced in, not missed.

TSLA trades at a 170x forward P/E with zero insider buying and flagged dilution/concentration anti-signals; the dossier explicitly notes no material edge over the consensus, failing the <50 skip threshold and the anti-signal gates.

TSLA presents a classic fully-valued mega-cap with an extreme forward P/E of 170x that forecloses any credible asymmetric long thesis. The stock has recovered ~20% from its March lows ($343) to $428 but sits ~14% below its 52-week high ($498). Q1 2026 showed solid execution (EPS beat at $0.41 vs $0.35 estimate, +17.15%) with revenue growth normalizing into the mid-teens after prior hypergrowth. The SpaceX IPO (~2T valuation expected) is drawing speculative capital away from TSLA, creating near-term headwinds rather than a catalyst. Insider activity is entirely routine option-exercise selling (no open-market CEO/CFO buys). The options flow showing 59% net dollar bullish bias and 10 OTM call whale blocks reflects elevated IV premium — not fundamental conviction — making covered calls and strangles the appropriate structures, not directional calls.

Extreme valuation (176x FPE, 148x EV/EBITDA) combined with triggering anti-signal gates (structural dilution risk from executive compensation/option exercises, pump-like retail flow) makes this a speculative trade with no margin of safety. The dossier's range-bound verdict and zero insider buying confirm the absence of an asymmetric opportunity.

Tesla presents a fundamentally healthy business with dramatically improved Q1 2026 gross margins (21.1% vs 16.3% YoY) that surprised consensus — but trades at a forward P/E of ~176x against an auto sector median of roughly 10-15x. The bull thesis rests entirely on AI-narrative execution (FSD licensing in China, Robotaxi scaling, Optimus commercialization). No open-market insider buys were detected; insiders are exercising vested options and selling for tax withholding, which is neutral-to-bearish as a signal. Options flow confirms 19 OTM call whale blocks with strong directional bias toward calls, consistent with the speculative positioning of retail traders chasing the Musk/AI narrative rather than fundamental value investors. Earnings on July 22 represent the nearest identifiable catalyst. At ~11% off its 52-week high and RSI at 69, near-term upside appears limited while downside risk to a sector-average valuation multiple is substantial.

Elevated valuation (162x Fwd P/E) and active anti-signal gates (dilution overhang, related-party revenue concentration, CEO focus) outweigh the modest options flow and technical setup. The dossier correctly identifies a range-bound environment where risk/reward does not justify a new position.

TSLA is a $1.55T mega-cap dual-segment company (automotive + energy generation & storage) pivoting hard toward AI real-world applications — FSD Supervised, Robotaxi (launched June 2025), and Optimus humanoid robots. The stock trades at ~17% below its 52w high of $498.83 on the back of strong Q1 2026 EPS beat (+17.15%) and China export momentum, but sits at a forward P/E of 162x — roughly 10-15x the auto sector median. No insider open-market purchases were found in the trailing 90 days; CEO Elon Musk received a massive restricted stock award grant (12-tranche performance plan up to ~423M shares) and a simultaneous forfeiture event, with director-level selling via scheduled 10b5-1 plans dominating recent Form 4 activity. The options flow on expiry 2026-06-12 shows genuine bullish whale call blocks but concentrated in speculative OTM territory rather than strategic deep-ITM accumulation. At this valuation — fully priced for an extraordinary AI/robotaxi future — there is no compelling asymmetric long thesis, and the elevated IV environment makes a structured income strategy (covered calls) the appropriate vehicle if the Analyst wants exposure.

Score of 32/100 reflects extreme valuation (162x Fwd P/E) and zero insider buying. The >10% dilution gate from CEO share awards is active, and with no fundamental margin of safety or catalyst within 30 days, neither long nor income structures justify the risk at current levels.

TSLA is a deeply researched mega-cap at extreme valuation (forward P/E ~162x, EV/EBITDA ~132x) that the market treats as an AI/robotics story rather than an auto manufacturer. Smart-money signals are neutral: no open-market insider purchases in 90 days; all Form 4 activity from named insiders is 10b5-1 pre-planned selling or a routine CEO equity award issuance (no new capital deployed). The Q1 2026 beat (+17% EPS surprise) and China export surge (+36% April Y/Y) are genuine positives, but the stock has already rallied ~19% year-to-date and sits near the top of its 52-week range. Options flow is genuinely bullish with strong OTM call whale blocks at $420 (V/OI = 9.5x), corroborating a short-term momentum thesis — yet the valuation framework offers no margin-of-safety for long-stock holders. The Analyst should weight whether the income premium from elevated IV (44-46% ATM on Jun 12) justifies structuring a covered-call or strangle rather than chasing upside.